Latest round

Series A

Last raised

Oct 2026

Total raised

$41M

Investors

9

About mbiomics

Founded in 2020 and based in Munich, Germany, Mbiomics GmbH operates as a biotechnology company that focuses on researching therapeutic approaches using the microbiome. Laura Figulla (CEO), Markus Rinecker (CMO/CFO), Johannes B. Woehrstein (CTO), and Heinrich Grabmayr are the co-founders of the company. The company offers a variety of products, such as Mbiomics Gold, the gold standard for microbiome analysis, which allows for comparable gut microbiome profiling; Mbiomics Monitor, which enables users to monitor microbiome modulation with sampling frequency; and the Mbiomics Stratos Platform, which enables microbiome profiling by combining biomarker panels and turnaround times. The firm’s partners include the University of Zurich and TUM.

Who invested in mbiomics

9 investors across 3 rounds

See all investors in mbiomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 16, 2026

    Amount

    $13M

    Investors

    Locked

  2. Series A

    Apr 15, 2026

    Amount

    $14M

    Investors

    Locked

  3. Series A

    Mar 20, 2023

    Amount

    $14M

    Investors

    Locked

Questions about mbiomics

Who invested in mbiomics?

mbiomics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has mbiomics raised?

mbiomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did mbiomics last raise money?

mbiomics's most recent round on record is a Series A, in Oct 2026.

What does mbiomics do?

Founded in 2020 and based in Munich, Germany, Mbiomics GmbH operates as a biotechnology company that focuses on researching therapeutic approaches using the microbiome.

Where is mbiomics headquartered?

mbiomics is headquartered in Germany.

Which VCs invest in companies like mbiomics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at mbiomics's stage. Their profiles are linked below.

Raising like mbiomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.